Tolero Pharmaceuticals
A biopharmaceutical company, develops novel therapeutics to treat cancer and other life-threatening diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
$33—49m (Dealroom.co estimates Nov 2014.)
Salt Lake City Utah (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $3.3m | Debt | |
N/A | $200k | Grant | |
$14.2m | Series B | ||
$8.2m | Series B | ||
$780m | Acquisition | ||
Total Funding | $22.6m |
Recent News about Tolero Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.